Background: The novel coronavirus pneumonia (COVID-19), which was first detected in Wuhan City, has now became a pandemic that affecting patients around the world. Particularly, the community patient population are at high risk of infection and are facing potential failure of proper medication use during the pandemic.
Objective: To discuss community pharmacists' role and the content of pharmaceutical care (PC) during the novel coronavirus pandemic to promote effective prevention and control and safe drug use of the community patient population.
Method: Collect and summarize the experience Chinese community pharmacies gained from providing pharmacy services during the COVID-19 outbreak, and taking patients' PC needs into consideration, analyze and discuss the methods and strategies that community pharmacies and pharmacists shall use to provide PC during the pandemic.
Results: Community pharmacy management teams shall support PC services by providing adequate supply of COVID-19 related medications and preventative products, following environment regulations, and providing sufficient staff trainings. Pharmacists shall use various approaches to provide PC services in drug dispensing, consulting and referrals, chronic disease management, safe use of infusions, patient education, home care guidance and psychological support to promote the COVID-19 pandemic control and ensure safe medication use of community patients during the pandemic.
Conclusion: PC services in communities during the COVID-19 shall possess different properties due to disease characteristics and related change in patients' need. Community pharmacies shall work as a strong supporter of patient's medication and protective equipment supply. Community pharmacists shall be prepared to provide skilled and effective PC services for community patient population to ensure medication safety and promote the overall COVID-19 pandemic control.
Keywords: COVID-19; Community pharmacy; Novel coronavirus pneumonia; Pharmaceutical care; Safe medication use.
Copyright © 2020 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interest To the best of our knowledge, the named authors have no conflict of interest, financial or otherwise, of the submitted work.
Hospital pharmacists' pharmaceutical care for hospitalized patients with COVID-19: Recommendations and guidance from clinical experience.Res Social Adm Pharm. 2020 Apr 3. doi: 10.1016/j.sapharm.2020.03.027. Online ahead of print. Res Social Adm Pharm. 2020. PMID: 32273253 Free PMC article.
Pharmacy Emergency Preparedness and Response (PEPR): a proposed framework for expanding pharmacy professionals' roles and contributions to emergency preparedness and response during the COVID-19 pandemic and beyond.Res Social Adm Pharm. 2020 Apr 10:S1551-7411(20)30323-5. doi: 10.1016/j.sapharm.2020.04.002. Online ahead of print. Res Social Adm Pharm. 2020. PMID: 32389631 Free PMC article.
Drugs supply and pharmaceutical care management practices at a designated hospital during the COVID-19 epidemic.Res Social Adm Pharm. 2020 Apr 6:S1551-7411(20)30325-9. doi: 10.1016/j.sapharm.2020.04.001. Online ahead of print. Res Social Adm Pharm. 2020. PMID: 32317153 Free PMC article.
Fighting against COVID-19: Innovative strategies for clinical pharmacists.Res Social Adm Pharm. 2020 Apr 6:S1551-7411(20)30328-4. doi: 10.1016/j.sapharm.2020.04.003. Online ahead of print. Res Social Adm Pharm. 2020. PMID: 32278766 Free PMC article. Review.
Pharmaceutical care in community pharmacies: practice and research in the US.Ann Pharmacother. 2006 Jul-Aug;40(7-8):1400-6. doi: 10.1345/aph.1G545. Ann Pharmacother. 2006. PMID: 16868221 Review.
Cited by 2 articles
Internet of things (IoT) applications to fight against COVID-19 pandemic.Diabetes Metab Syndr. 2020 May 5;14(4):521-524. doi: 10.1016/j.dsx.2020.04.041. Online ahead of print. Diabetes Metab Syndr. 2020. PMID: 32388333 Free PMC article.
Pharmacists at the frontline beating the COVID-19 pandemic.Version 2. J Pharm Policy Pract. 2020 Apr 20;13:8. doi: 10.1186/s40545-020-00210-w. eCollection 2020. J Pharm Policy Pract. 2020. PMID: 32328285 Free PMC article.
- Chinese Pharmaceutical Association CORONAVIRUS SARS-CoV-2 INFECTION: Expert Consensus on guidance and prevention strategies for hospital pharmacists and the pharmacy workforce (2nd edition) [EB/OL]. [2020-03-03] http://www.cpa.org.cn/cpadmn/attached/file/20200216/1581854567839722.pdf
- International Pharmaceutical Federation CORONAVIRUS SARS-CoV-2 OUTBREAK: information and interim guidelines for pharmacists and the pharmacy workforce [EB/OL]. [2020-03-03] https://www.fip.org/file/4428
- National Health Commission of the People’s Republic of China Diagnosis and treatment plan for patients with novel coronavirus pneumonia (6th trial version) [EB/OL]. [2020-02-20] http://www.nhc.gov.cn/yzygj/s7653p/202002/8334a8326dd94d329df351d7da8aefc2/files/b218cfeb1bc54639af227f922bf6b817.pdf
- Wei M., Chen Q., Yu D.M. The development of pharmaceutical care in domestic and foreign communities and its enlightenment on establishing pharmacy major in China [J] Chin Pharmaceut J. 2010;(12):98–100.
- Centers for Disease Control and Prevention Evaluating and reporting persons under investigation (PUI) [EB/OL]. [2020-03-04] https://www.cdc.gov/coronavirus/2019-nCoV/hcp/clinical-criteria.html